We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 11,509

2017 Antitrust Annual Report
  • Shearman & Sterling LLP
  • European Union, USA
  • March 20 2017

On February 4, 2015, Staples and Office Depot announced their proposed merger. On December 7, 2015, the Federal Trade Commission (FTC) filed a


BPCIA Helps Amgen Gain Dismissal of Genentech Complaint
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • March 20 2017

Recently, the U.S. District Court of Delaware dismissed a complaint filed by Genentech under the Biologics Price Competition and Innovation Act


Tenth Circuit Affirms Dismissal of Antitrust Tying and Bundling Claims
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • March 20 2017

The Court of Appeals for the Tenth Circuit recently affirmed the dismissal of claims by a medical products distributor that two of its competitors


Tenth Circuit Sides with Defendants in $200 Million Sutures Bundling Case
  • McDermott Will & Emery
  • USA
  • March 16 2017

In an antitrust case involving bundled discount on sutures, the United States Court of Appeals for the Tenth Circuit affirmed a lower court decision


Lawsuit Highlights Antitrust Exposure Related to Hiring and Compensation
  • Reed Smith LLP
  • USA
  • March 16 2017

A recently filed class action lawsuit serves as an important reminder that employers can face scrutiny under antitrust law through civil litigation


DOJ’s Antitrust Division Convicts Fifth Extradited Foreign Executive
  • Morgan Lewis & Bockius LLP
  • USA
  • March 16 2017

On March 13, 2017, the Antitrust Division (Antitrust Division) of the US Department of Justice (DOJ) convicted its fifth foreign executive who was


M&A Strategic Planning
  • McDermott Will & Emery
  • USA
  • March 16 2017

The health system's M&A planning should closely consider the implications of the government's latest litigation victory in its challenge to a


Antitrust Not Always Available in Competitor Disputes in the Healthcare Sector
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • March 16 2017

The antitrust injury and antitrust standing defensesdoctrines are alive and well in healthcare. A recent case, SCPH Legacy Corp. et al. v. Palmetto


DOJ and FTC Issue Updates to Antitrust Guidelines for the Licensing of Intellectual Property for the First Time Since 1995
  • Miller Canfield PLC
  • USA
  • March 15 2017

For the first time, the Department of Justice (“DOJ”) and the Federal Trade Commission (“FTC”) have updated the Antitrust Guidelines for the Licensing


Losing Bidder for Pharmaceutical Triggers FTC Investigation, Fix, and $100 Million Fine in Non-HSR-Reportable Transaction
  • McDermott Will & Emery
  • USA
  • March 13 2017

A private lawsuit filed by Retrophin Inc. (Retrophin), under then-CEO Martin Shkreli, likely triggered an investigation by the FTC into a consummated